Cargando…
Treatment-resistant schizophrenia: How far have we traveled?
Treatment-resistant schizophrenia is a lack of adequate response to antipsychotic medications resulting in incomplete functional and social recovery from the illness. Different definitions have been proposed for clinical practice and research work. Antipsychotics that are used in the management of s...
Autores principales: | Pandey, Ambu, Kalita, Kamal Narayan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468267/ https://www.ncbi.nlm.nih.gov/pubmed/36111312 http://dx.doi.org/10.3389/fpsyt.2022.994425 |
Ejemplares similares
-
Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
por: van Westrhenen, Roos, et al.
Publicado: (2020) -
Editorial: Functional neuroimaging in psychiatric practice: How far have we come?
por: Kundu, Prantik
Publicado: (2023) -
Value‐based primary care in Australia: how far have we travelled?
por: Dawda, Paresh, et al.
Publicado: (2022) -
Precision Medicine in Solid Tumors: How Far We Traveled So Far?
por: Dey, Nandini, et al.
Publicado: (2022) -
Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
por: Gajjela, Harini, et al.
Publicado: (2021)